ES2485867T3 - Compuestos opioides de carboxamido - Google Patents

Compuestos opioides de carboxamido Download PDF

Info

Publication number
ES2485867T3
ES2485867T3 ES05757373.5T ES05757373T ES2485867T3 ES 2485867 T3 ES2485867 T3 ES 2485867T3 ES 05757373 T ES05757373 T ES 05757373T ES 2485867 T3 ES2485867 T3 ES 2485867T3
Authority
ES
Spain
Prior art keywords
opioid
alkyl
hydrogen
carboxamide compounds
alkyldiyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES05757373.5T
Other languages
English (en)
Inventor
John R. Carson
Philip M. Pitis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35064532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2485867(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2485867T3 publication Critical patent/ES2485867T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/38—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Abstract

Un compuesto de la Fórmula (I)**Fórmula** donde: R1 y R2 se seleccionan independientemente del grupo consistente en hidrógeno, C1-4 alquilo y alquildiil donde R1 y R2 se toman junto con los átomos a los que están unidos para formar un anillo monocíclico; R3 y R4 se seleccionan independientemente del grupo consistente en hidrógeno, C1-4 alquilo, C3-7 cicloalquilo y alquildiil donde R3 y R4 se toman junto con los átomos a los que están unidos para formar un anillo monocíclico; Y es hidrógeno, C1-4 alquilo, C1-4 alcoxi, halógeno o trifluorometilo; y enantiómeros, diastereómeros, tautómeros, solvatos y sales de los mismos farmacéuticamente aceptables.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12

Claims (1)

  1. imagen1
    imagen2
ES05757373.5T 2004-05-14 2005-05-11 Compuestos opioides de carboxamido Active ES2485867T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57129804P 2004-05-14 2004-05-14
US571298P 2004-05-14
PCT/US2005/016581 WO2005113486A1 (en) 2004-05-14 2005-05-11 Carboxamido opioid compounds

Publications (1)

Publication Number Publication Date
ES2485867T3 true ES2485867T3 (es) 2014-08-14

Family

ID=35064532

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05757373.5T Active ES2485867T3 (es) 2004-05-14 2005-05-11 Compuestos opioides de carboxamido

Country Status (22)

Country Link
US (2) US7244866B2 (es)
EP (1) EP1748978B1 (es)
JP (1) JP5420170B2 (es)
KR (1) KR101204751B1 (es)
CN (1) CN1984879B (es)
AR (1) AR049276A1 (es)
AU (1) AU2005245403B2 (es)
BR (1) BRPI0511137A (es)
CA (1) CA2566601C (es)
CR (1) CR8811A (es)
EA (1) EA013261B1 (es)
EC (1) ECSP067008A (es)
ES (1) ES2485867T3 (es)
HK (1) HK1101246A1 (es)
IL (1) IL179196A (es)
MX (1) MXPA06013270A (es)
NO (1) NO20065768L (es)
NZ (1) NZ551288A (es)
TW (1) TWI418345B (es)
UA (1) UA90432C2 (es)
WO (1) WO2005113486A1 (es)
ZA (1) ZA200610446B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0511137A (pt) * 2004-05-14 2007-11-27 Janssen Pharmaceutica Nv compostos opióides de carboxamido
US20060254029A1 (en) * 2005-05-11 2006-11-16 Conrad Swenson Pocket loss prevention device
KR101581289B1 (ko) * 2007-05-31 2015-12-31 세프라코 아이엔시. 모노아민 재흡수 억제제로서 페닐 치환된 시클로알킬아민
CA2754984C (en) * 2009-03-19 2018-06-26 Alkermes, Inc. Morphinan derivatives with high oral bioavailability
HUE043963T2 (hu) * 2009-12-04 2019-09-30 Alkermes Pharma Ireland Ltd Morfinán származékok gyógyszer-túladagolás kezelésére
SI3446565T1 (sl) 2010-08-23 2024-03-29 Alkermes Pharma Ireland Limited Metode zdravljenja povečanja teže, povzročene z antipsihotiki
US9029543B2 (en) 2011-04-05 2015-05-12 Alkermes, Inc. Process for the synthesis of quaternary amine compounds
BR112014012409B8 (pt) 2011-12-15 2022-09-13 Alkermes Pharma Ireland Ltd Composições de buprenorfina e antagonistas do receptor mu-opioide
US9211293B2 (en) 2011-12-15 2015-12-15 Alkermes Pharma Ireland Limited Opioid agonist antagonist combinations
WO2014190271A2 (en) 2013-05-24 2014-11-27 Alkermes Pharma Ireland Limted Methods for treating depressive symptoms
JP2016519161A (ja) 2013-05-24 2016-06-30 アルカームス ファーマ アイルランド リミテッド モルファン及びモルフィナン類似物及び使用の方法
CN104940709A (zh) * 2015-07-22 2015-09-30 张秋英 一种镇痛麻醉喷雾剂
CN105055756A (zh) * 2015-09-18 2015-11-18 张秋英 一种阴部挫伤用镇痛气雾剂
EP3570838A4 (en) 2017-01-17 2021-01-27 Mebias Discovery, Inc. SUBSTITUTED 3-DIALKYLAMINOMETHYL-PIPERIDINE-4-YL-BENZAMIDE AND METHOD FOR MANUFACTURING AND USING THEREOF
EP4243768A1 (en) 2020-11-12 2023-09-20 Alkermes Pharma Ireland Limited Immediate release multilayer tablet

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0507863A4 (en) * 1989-12-28 1993-07-07 Virginia Commonwealth University Sigma receptor ligands and the use thereof
US6071970A (en) * 1993-02-08 2000-06-06 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
CA2426942C (en) * 2000-10-31 2014-06-03 Mark P. Wentland 8-carboxamido-2,6-methano-3-benzazocines
DE10059413A1 (de) * 2000-11-30 2002-06-20 Gruenenthal Gmbh Verwendung von substituierten 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
US6780891B2 (en) * 2001-11-30 2004-08-24 Sepracor Inc. Tramadol analogs and uses thereof
DE10213051B4 (de) 2002-03-23 2013-03-07 Grünenthal GmbH Substituierte 4-Aminocyclohexanole
UA84277C2 (ru) * 2002-10-25 2008-10-10 Лабофарм Инк. Композиция трамадола с пролонгированным высвобождением с 24-часовым действием
SI1725537T1 (sl) 2004-03-15 2011-11-30 Janssen Pharmaceutica Nv Nove spojine kot modulatorji opioidnih receptorjev
BRPI0511137A (pt) * 2004-05-14 2007-11-27 Janssen Pharmaceutica Nv compostos opióides de carboxamido

Also Published As

Publication number Publication date
AU2005245403B2 (en) 2012-04-19
ECSP067008A (es) 2006-12-29
NZ551288A (en) 2010-10-29
KR101204751B1 (ko) 2012-11-27
MXPA06013270A (es) 2007-04-23
IL179196A (en) 2012-10-31
EP1748978A1 (en) 2007-02-07
NO20065768L (no) 2007-02-07
AU2005245403A1 (en) 2005-12-01
BRPI0511137A (pt) 2007-11-27
IL179196A0 (en) 2007-03-08
EA013261B1 (ru) 2010-04-30
UA90432C2 (uk) 2010-04-26
JP2007537278A (ja) 2007-12-20
US20050256203A1 (en) 2005-11-17
US20080280990A1 (en) 2008-11-13
US7745492B2 (en) 2010-06-29
JP5420170B2 (ja) 2014-02-19
US7244866B2 (en) 2007-07-17
TW200605871A (en) 2006-02-16
CN1984879B (zh) 2011-07-27
EA200602115A1 (ru) 2007-04-27
CN1984879A (zh) 2007-06-20
TWI418345B (zh) 2013-12-11
EP1748978B1 (en) 2014-06-04
ZA200610446B (en) 2008-07-30
CA2566601C (en) 2013-04-09
AR049276A1 (es) 2006-07-12
CR8811A (es) 2009-01-14
CA2566601A1 (en) 2005-12-01
HK1101246A1 (en) 2007-10-12
WO2005113486A1 (en) 2005-12-01
KR20070015613A (ko) 2007-02-05

Similar Documents

Publication Publication Date Title
ES2485867T3 (es) Compuestos opioides de carboxamido
ES2528797T3 (es) Compuestos de aza-benzotiofenilo y métodos de uso
AR056764A1 (es) Aminopirimidinas utiles como inhibidores de quinasa
RS50574B (sr) (4-metoksi-7-morfolin-4-il-benzotiazol-2-il)-amid 4-hidroksi-4-metil-piperidin-1-karboksilne kiseline
HRP20080666T3 (en) Cgrp receptor antagonists
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
RS52978B (en) FUSIONED AMINO PIRIDIN AS HSP90 INHIBITORS
AR048641A1 (es) Compuestos de aril- o heteroarilamida ortosustituidos utiles como antago-nistas del receptor de prostaglandinas e2; composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicame
ECSP034865A (es) Resolución óptica de (1-benzilo-4-metilopiperidina-3-il)-metilamina y su uso para la preparación de derivados de pirrolo 2,3-pirimidina como inhibidores de proteina quinasas
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
AR025975A1 (es) Compuestos quimicos.
ES2192397T3 (es) Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico.
EA200602060A1 (ru) Производные пирролидин-2-она и пиперидин-2-она, используемые в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы
ME01992B (me) Jedinjenje diarilhidantoina
CO6270328A2 (es) Derivados de pirrolo [2,3] pirimidina como inhibidores de proteinas quinasas b
AR038341A1 (es) Compuestos que son agonistas de receptores alfa-1 preferentemente agonistas de receptores alfa-1a/l
CO6220931A2 (es) Inhibidores de serina proteasas para el tratamiento de infecciones de vhc
AR043111A1 (es) Derivados monoacilados de o-fenilendiaminas
ATE380818T1 (de) Piperazine-substituierte aryl-benzodiazepinen und ihre verwendung als dopaminrezeptor-antagonisten zur behandlung von psychose
NI200900021A (es) Inhibidor de quinasa
RS20100169A (en) INTERMEDIATES FOR DIOXAN-2-ALKYLCARBAMATE
NO20092372L (no) Substituerte acetofenoner anvendelige som PDE4-inhibitorer
AR057464A1 (es) Procedimiento para la preparacion de derivados de sulfonamida
DK1485377T5 (da) Pyranoner egnede som ATM-inhibitorer
CO5700781A2 (es) Agonistas morfolinicos de la dopamina